October 24, 2012
Hahnemann University Hospital has not ordered or used any New England Compounding Center (NECC) methylprednisolone, the steroid linked to the recent fungal meningitis outbreak.
We have ordered and used products from the NECC during the time period currently being investigated by the Food and Drug Administration (FDA). These products include: • Cardioplegia, a drug used during heart surgery;
• Injectable ophthalmics; and
• Ophthalmic solutions used during eye surgery and other injectables
We are no longer using NECC products and they have been removed from our pharmacy inventory. None of the products previously used by our hospital has been linked to the outbreak of meningitis or other infections.
Out of an abundance of caution, the FDA has asked all health care providers to notify patients who may have received these medications. We are identifying all patients who may be impacted and are notifying them this week. Ensuring high-quality care and the safety of our patients is our highest priority and we will continue to monitor the situation closely.
Patients who may have received one of these drugs can call our Patient Information Line at 877-929-6238. For more information about the recall, visit www.cdc.gov
Terms And Conditions
Notice of Privacy Practices
Hahnemann University Hospital | 230 N Broad St, Philadelphia, PA 19102
© 2002-2014 Hahnemann University Hospital, All Rights Reserved.